Malignancy associated changes (MAC) in blood and bone marrow cells of patients with malignant tumors.
D001773:Blood Cells / Q000473:pathology*; D001853:Bone Marrow / Q000473:pathology*; D001854:Bone Marrow Cells; D002430:Cecal Neoplasms / Q000473:pathology; D006801:Humans; D007680:Kidney Neoplasms / Q000473:pathology; D007962:Leukocytes / Q000473:pathology; D008297:Male; D008533:Megakaryocytes / Q000473:pathology; D009000:Monocytes / Q000473:pathology; D009369:Neoplasms / Q000473:pathology*; D009360:Neoplastic Cells, Circulating / Q000473:pathology*; D009504:Neutrophils / Q000473:pathology; D011471:Prostatic Neoplasms / Q000473:pathology; D001749:Urinary Bladder Neoplasms / Q000473:pathology